North America Accounted for the Largest Share to the Global Microfluidics Market

Date: 2015-09-10

“Over the past five years, the microfluidics market has witnessed tremendous growth primarily due to rising demand for point-of-care (POC) testing, increasing use of miniaturized microfluidic chips to achieve faster testing and improved portability, and increased prevalence of age-related and lifestyle diseases and disorders.

The global microfluidics market is expected to grow at a significant CAGR of around 19% during the forecast period (2015 to 2020). The market is mainly driven by the rising geriatric population, growing Asian healthcare market, and upsurge in government and corporate funding for R&D. However, lack of adequate healthcare and research infrastructure in emerging markets, dearth of skilled professionals in clinical laboratories, and high prices of integrated instruments and microfluidics chips are hampering the growth of this market to a certain extent.

In this report, the global microfluidics market is segmented on the basis of materials and applications. On the basis of applications, the microfluidics market is divided into pharmaceutical research, in vitro diagnostics, and drug delivery. The pharmaceutical research segment is further divided into lab analytics (cell-based assays, proteomic analysis, genomic analysis, and capillary electrophoresis), dispensing, and microreaction. The in vitro diagnostics segment is categorized into clinical diagnostics, point-of-care testing, environmental testing, industrial testing, and agro food testing. The drug delivery segment is subsegmented into inhalers, microneedles, and micropumps. On the basis of materials, the microfluidics market is divided into polymer-based microfluidics, glass-based microfluidics, silicon-based microfluidics, and other material-based microfluidics. In addition, country-wise segmentation of each region (North America, Europe, Asia-Pacific, and the Rest of the World) is also provided in the report.

The in vitro diagnostics application segment accounted for a major share of the microfluidics market. This market is primarily driven by the rising demand for point-of-care testing, rising incidences of lifestyle disorders and diseases, growing geriatric population, and rapidly improving healthcare infrastructure in Asian countries. 

In 2014, North America accounted for the largest share to the global microfluidics market, followed by Europe, Asia-Pacific, and RoW. However, Asia-Pacific is expected to be the fastest-growing region during the forecast period owing to the rapidly aging population, increased accessibility to healthcare facilities, and rising R&D and healthcare expenditure.

The global microfluidics market is highly fragmented; some of the major players in this market are Danaher Corporation (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Becton, Dickinson and Company (U.S.), Agilent Technologies, Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), and PerkinElmer, Inc. (U.S.).

Contact With Us
Join templatemonster at google+
Customized Research
Request Sample